We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Protein Found to Limit Damage of Acute Brain Injury

By Biotechdaily staff writers
Posted on 31 Jul 2003
Scientists have identified a protein with the ability to limit nuerologic damage induced by stroke or trauma and thereby has the potential to improve the long-term outcome of acute brain injury. More...
Their findings were reported in the July 13, 2003, online issue of Nature Medicine.

In the process of identifying new mechanisms of brain protection by using a genomics approach, the researchers found the gene encoding uncoupling protein-2 (UCP-2) to be up-regulated in response to short episodes of reduced blood flow. Further analysis revealed that UPC-2 displayed a marked neuroprotective effect in experimental mouse models of stroke and brain trauma and in vitro models of neuronal death, indicating that UCP-2 is potentially protective against human stroke and brain trauma. The research was conducted by AGY Therapeutics, Inc. (So. San Francisco, CA, USA; www.agyinc.com), in collaboration with scientists at the Wallenberg Neuroscience Center (Sweden), the State University of Campinas (Brazil), and the University of California, Davis (USA).

"Following stroke or serious head injury, a cascade of events is initiated in the vicinity of the damage that results in the programmed cell death of neurons, which is responsible for many of the long-term debilitating effects of brain trauma,” said Karoly Nikolich, Ph.D., founder and chief scientific officer, AGY Therapeutics.”




Related Links:
AGY

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
New
HPV Molecular Test
BD Onclarity HPV Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.